Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- MEIP
- Price
- 2.20
- Stock movement up
- +0.03 (0.65%)
- Company name
- MEI Pharma Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 151.71M
- Ent value
- 147.63M
- Price/Sales
- -
- Price/Book
- 6.10
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -53.68%
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- 49.03%
- 3 year return
- -24.84%
- 5 year return
- -39.29%
- 10 year return
- -17.85%
Last updated: 2025-09-15
DIVIDENDS
MEIP does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | - |
| Price to Book | 6.10 |
| EV to Sales | - |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 32.84M |
| EPS (TTM) | -6.99 |
| FCF per share (TTM) | -6.52 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 0.00 |
| Gross profit (TTM) | -3.95M |
| Operating income (TTM) | -49.09M |
| Net income (TTM) | -46.60M |
| EPS (TTM) | -6.99 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | - |
| Operating margin (TTM) | - |
| Profit margin (TTM) | - |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 6.95M |
| Net receivables | 0.00 |
| Total current assets | 27.75M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 7.00K |
| Total assets | 27.75M |
| Accounts payable | 976.00K |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 2.87M |
| Total liabilities | 2.87M |
| Shareholder's equity | 24.88M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -43.43M |
| Capital expenditures (TTM) | 7.00K |
| Free cash flow (TTM) | -43.44M |
| Dividends paid (TTM) | 23.32M |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -187.33% |
| Return on Assets | -167.94% |
| Return on Invested Capital | -187.33% |
| Cash Return on Invested Capital | -174.61% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 4.60 |
| Daily high | 4.70 |
| Daily low | 4.60 |
| Daily Volume | 237K |
| All-time high | 15324.00 |
| 1y analyst estimate | 20.00 |
| Beta | 0.21 |
| EPS (TTM) | -6.99 |
| Dividend per share | - |
| Ex-div date | 16 Nov 2023 |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| MEIP | S&P500 | |
| Current price drop from All-time high | -99.97% | -1.46% |
| Highest price drop | -99.99% | -56.47% |
| Date of highest drop | 8 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -89.71% | -10.99% |
| Avg time to new high | 680 days | 12 days |
| Max time to new high | 5401 days | 1805 days |
COMPANY DETAILS
Marketcap
151.71M
Marketcap category
Small-cap
Description
MEI Pharma, Inc., a clinical-stage pharmaceutical company, focuses on the development of various therapies for the treatment of cancer. It develops ME-344, an intravenous small molecule inhibitor mitochondrial oxidative phosphorylation to treat human epidermal growth factor receptor 2 negative breast cancer, colorectal cancer, and solid tumors. The company was formerly known as Marshall Edwards, Inc. and changed its name to MEI Pharma, Inc. in July 2012. MEI Pharma, Inc. was incorporated in 2000 and is headquartered in San Diego, California.
Employees
28
Website
Investor relations
-
SEC filings
CEO
Daniel P. Gold
Country
USA
City
San Diego
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
No items found
iO Charts is a Seeking Alpha partner